The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regionsRachel Sze Jen Goh, Duk‐Woo Park, Kannan Shankar et al.|The Lancet Regional Health - Western Pacific|2024Cited by 75
Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trialsRuth Sim, Shaun Wen Huey Lee, Chun Wie Chong et al.|Diabetic Medicine|2021Cited by 33
Obesity in the Asia-Pacific Region: Current PerspectivesDavid Tak Wai Lui, Kathryn Choon Beng Tan, Junya Ako et al.|Journal of Asian Pacific Society of Cardiology|2024Cited by 31